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Multivalent particles, i.e. microscopic constructs having multiple ligands, can be used to target surfaces
selectively depending on their receptor density. Typically, there is a sharp onset of multivalent binding as
the receptor density exceeds a given threshold. However, the opposite case, selectively binding to surfaces
with a receptor density below a given threshold, is much harder. Here, we present a simple strategy for
selectively targeting a surface with a low density of receptors, within a system also having a surface with
a higher density of the same receptors. Our strategy exploits competitive adsorption of two species. The
first species, called “guards”, are receptor-sized monovalent particles designed to occupy the high-density
surface at equilibrium, while the second multivalent “attacker” species outcompetes the guards for binding
onto the low-density surface. Surprisingly, the recipe for attackers and guards yields more selective binding
with stronger ligand-receptor association constants, in contrast to standard multivalency. We derive explicit
expressions for the attacker and guard molecular design parameters and concentrations, optimised within
bounds of what is experimentally accessible, thereby facilitating implementation of the proposed approach.
I. INTRODUCTION
Multivalency is a microscopic design strategy for tar-
geting particles with two or more binding units (“lig-
ands”) to a target, such as a surface, having comple-
mentary binding units (“receptors”).1–8 Nature has ex-
ploited multivalency to define interaction paradigms at
and between cell surfaces1–3,9–22, and in the design of
bacteria, viruses, and biomolecules themselves.23–26 As
a result, a large body of research to date has been
dedicated to targeting surfaces of cells, cancerous tu-
mours, and other microscopic objects via bio-inspired
multivalent interactions.14,15,25–44 Multivalency is also
employed to design eloquent self-assembly pathways for
synthetic ligand-coated nano- and colloidal particles, of-
ten utilising DNA as their binding moities due to their
tunable hybridisation free energy.6,7,36,45–68 Due to the
fact that multiple ligand-receptor bonds are involved
in multivalent interactions, their binding kinetics are
non-trivial and can complicate the road to reaching
equilibrium.18,31,59,62,69,70
The binding affinity of a multivalent particle depends
strongly on the number of ligands it has, and the recep-
tor density of the target surface.5,6,71 This is because the
binding free energy between the two entities contains a
non-trivial entropy term, whose magnitude depends on
the number of ligands and receptors. One result of this
is superselectivity, where the logarithm of the number of
surface-bound particles increases super-linearly with the
log of the surface receptor concentration.5 The selectivity
becomes larger for particles with more ligands, and when
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the per-ligand binding energy becomes smaller. There-
fore, high-valence particles with weak-binding ligands ex-
hibit sharper surface binding transitions than low-valence
particles with strong-binding ligands. This can be used
to design multivalent particles that strongly bind to sur-
faces with many receptors, while having little affinity for
surfaces with even a slightly lower density of the same
receptors.
A single species of multivalent particles cannot ad-
dress the opposite scenario, namely targeting a low-
receptor-density surface but not one with a higher re-
ceptor density. This is because the entropy of binding—
the contribution arising from ligand-receptor bonding
permutations—always becomes more favorable for a mul-
tivalent particle as the surface receptor density increases.
Therefore, particles that bind to a surface with few recep-
tors will necessarily bind to one with many. To selectively
target only a low receptor density surface, a different ap-
proach is needed.
By separately tuning the entropy and energy of bind-
ing, mixtures of different kinds of multivalent particles
can exhibit “switch-like” surface binding.72 For exam-
ple, an equimolar mixture of low-valence nanoparticles
with strong-binding ligands can compete with a high-
valence weak-ligand species. Both nanoparticle species
have the same core size, and exclude the same area when
bound to the surface. When the surface receptor den-
sity is low, the low-valence species selectively binds to
the surface. Upon increasing the receptor concentration,
there is a switch-point, after which the surface becomes
occupied by the high-valence species. The surface recep-
tor density thus acts to shift the balance between the
entropic and energetic terms in the free energy of bind-
ing for the two species. The binding free energy of the
low-valence strong-binding species is dominated by the
ar
X
iv
:1
81
2.
07
92
2v
2 
 [c
on
d-
ma
t.s
of
t] 
 26
 A
pr
 20
19
2energetic term; on the other hand, the high-valence weak-
binding species has a substantial entropy of binding.
The present work takes this as inspiration, and devises
an “attacker and guard” strategy for selectively targeting
a surface with low receptor density within a system that
also has a surface with a higher density of the same re-
ceptors. This might be, for example, two populations of
cells in a suspension, with one population having a high
membrane concentration of a particular receptor, and the
other having a low concentration of the same receptors.
The strategy we propose entails using one species of
particles, called “guards”, to occupy the receptors on the
high-density surface. These particles have a size on the
order of a single receptor. A second larger species of
particles, called “attackers”, are then designed to out-
compete the guards for binding on the low-receptor-
density surface at equilibrium, but not on the high-
density surface. Experimental accessibility and robust-
ness are emphasised in devising this recipe. The strategy
may prove useful for selectively imaging cell surfaces in
vitro that have globally or locally low receptor density,
e.g. by making the attackers fluorescently active and the
guards not via a DNA-PAINT approach.73 This approach
may also have use in selective sequestration or aggrega-
tion of microscopic entities with a low receptor density,
in which the attackers act as the aggregating agents.
II. TUNING MULTIVALENT BINDING BY
MICROSCOPIC CONSTRUCTION
To begin, we briefly review how the binding free energy
of a multivalent particle dictates its affinity to binding to
a surface, as a function of the target surface’s receptor
density. This is important for understanding how to ma-
nipulate the binding affinity of two competing species for
the more complex case of targeting a low-receptor-density
surface.
The binding free energy of a multivalent particle is
given by the standard relation βG(NR) = − lnQ(NR)−
ln z, where Q is the partition function for the particle
when it is adjacent to the receptor surface, and z is the
fugacity of the particles in solution above the receptor
surface. The quantity NR is the number of receptors
that are accessible to the particle when it is adjacent to
the surface. This is defined as NR = σRa
2, where σR
is the number of receptors per unit area on the surface
(the “receptor density”), and a is the diameter of the
multivalent particle and its ligands. We refer to one a2-
sized area element of the receptor surface as a surface
“lattice site”.
Multivalent particles at low concentration can be as-
sumed to follow ideal gas statistics, in which the fugacity
z is related to the molar concentration “[C]” of the par-
ticles in solution by
[C] =
z
NAvex
. (1)
Here, NA is Avogadro’s number, and vex is the excluded
volume (or “localisation volume”) for one multivalent
particle. Note that vex must be in units of decimeters
3 in
order for the concentration [C] to be in the appropriate
units of moles / litre.
When a multivalent particle is adjacent to a binding
surface, it can have one or more additional “non-specific”
(i.e. non-multivalent) interaction free energy contribu-
tions. Collecting all of these additional contributions into
the quantity “GNS”, then the total binding free energy
of the multivalent particle is
βG(NR) = − lnQ(NR)− ln z + βGNS . (2)
Written this way, the partition function Q(NR) explicitly
contains only the “multivalent” ligand/receptor bonding
contributions to the binding free energy. Unless otherwise
noted, we henceforth set βGNS to zero, and focus atten-
tion on the multivalent binding contributions in Q(NR).
When receptors are immobile and uniformly placed on
the surface at a density of σR, the partition function
Q(NR) for a lattice site when occupied by a multivalent
particle is well described5,19 by
Q(NR) =
N∗∑
λ=0
(
NR
λ
)(
NL
λ
)
λ!e−βλf (3)
where f is the free energy for forming a single ligand-
receptor bond, NL is the effective number of ligands
on the multivalent particle that can access the sur-
face for receptor binding at any given time, and N∗ =
min (NR, NL). This expression effectively treats the re-
ceptors and ligands as an ideal gas within the surface
lattice site, while crucially enforcing that they each may
only have zero or one binding partner in any given mi-
crostate.
Note that the quantity NL is almost always less than
the total number of ligands on the particle. This is be-
cause not all ligands can simultaneously reach the recep-
tor surface for binding, depending on how the multiva-
lent particle is oriented relative to the surface. As an
example, for a large colloidal particle with short ligands,
a simple way to estimate NL is to multiply the average
grafting density σL of ligands on the colloid by the av-
erage contact area Acontact between the colloid and the
receptor surface. This “effective valence” AcontactσL is
much smaller than the “total” valence AtotalσL of the
colloid, where Atotal is the colloid’s total surface area.
For multivalent constructs, it is the “effective” valence
that dictates the binding behaviour, and this is what the
quantity NL signifies throughout our discussion.
Adding in Poisson fluctuations to the number of re-
ceptors in each lattice site considerably simplifies this
expression. With a Poisson distribution centered around
a mean value of NR receptors per lattice site, the prob-
ability the multivalent particle “sees” j receptors within
area a2 follows P (j;NR) = e
−NRN jR/j!. In this case, Eq.
3 simplifies to19
Q(NR) =
(
1 +NRe
−βf)NL . (4)
3FIG. 1. Multivalent binding probability (Eq. 6) (upper panels) and binding free energy (lower panels) as a function of the
number of receptors NR per surface lattice site of size a
2. In (a), the ligand-receptor binding free energy βf = −2 and number
of ligands NL = 8 are kept fixed, while the fugacity of the particles is set to ln z = −32,−29,−23 (purple, yellow, red). Vertical
dashed lines indicate inflection points for each adsorption profile. In (b), the particle ligand-receptor binding free energy is also
fixed at βf = −2, while the number of ligands on the particle is set to NL = 5, 8, 12 (purple, yellow, red). In each case, the
fugacity is adjusted such that the binding transition occurs at NR = 5.
Strictly speaking, this form is only exact when the cover-
age of bound multivalent particles on the receptor surface
is low, such that each bound particle can independently
sample the Poisson distribution of receptors. For higher
surface coverage, the adsorption statistics become multi-
Langmuir, and this must be calculated numerically (see
Ref. 74 for a mathematical and experimental discussion
of this regime). To proceed analytically for the present
discussion, we adopt Eq. 4 and then remark on po-
tential discrepancies compared to the more exact multi-
Langmuir adsorption later on in the discussion. Note
that Eq. 4 is also exact when the receptors are mobile
on the surface, non-depletable (i.e. coming from a grand
canonical reservoir), and at an average concentration of
NR per lattice site. However, for the present study we as-
sume that the receptors are immobile over the timescale
of multivalent particle binding and equilibration.
Given Q(NR) in Eq. 4, the binding free energy for a
multivalent particle is
βG(NR) = −NL ln
(
1 +NRe
−βf)− ln z + βGNS . (5)
The probability that a surface lattice site is occupied by
a multivalent particle is then
Pb(NR) =
e−βG(NR)
1 + e−βG(NR)
. (6)
When βG(NR) is greater than zero (i.e. an unfavourable
binding free energy change), then Pb(NR) goes to zero.
4Similarly, when βG(NR) is less than zero, corresponding
to a favourable free energy of binding, then Pb(NR) goes
to unity. Thus, βG(NR) = 0 corresponds to the binding
transition, and the derivative of βG(NR) with respect to
NR at βG(NR) = 0 reflects the sharpness of the transi-
tion.
Equation 5 shows us how the multivalent binding free
energy changes with NR, f , NL, z, and βGNS . The fu-
gacity z (∝ concentration [C]) shifts the binding free en-
ergy βG(NR) up or down by a constant. It therefore pro-
vides a convenient handle for adjusting the receptor den-
sity σR at which the adsorption transition occurs. This
is illustrated in Figure 1a. As the fugacity grows smaller,
then the overall binding free energy shifts higher (more
unfavourable). The receptor density σR where the ad-
sorption transition occurs correspondingly increases, and
the sharpness of the transition decreases (as the local
derivative of βG(NR) for increasing NR gets smaller).
The sharpness of the binding transition can be tuned
by adjusting the molecular construction of the multiva-
lent particle, via its valence NL and ligand-receptor bind-
ing strength f . Figure 1b shows examples of tuning the
adsorption sharpness by changing NL. In each case, the
fugacity has been tuned so that the adsorption transi-
tion is centered at NR = 5. Making NL larger causes
the gradient of βG(NR) with NR to be steeper and more
negative, leading to a sharper binding transition.
The free energy curves in Figures 1a and b can also be
vertically shifted by altering the “non-specific” binding
free energy βGNS . The quoted values of ln z in those
examples can, for example, be equivalently interpreted
as “effective” fugacities given by ln ztrue − βGNS , where
the former is the true solution fugacity determined by
the multivalent particle concentration. Since βGNS can
also be tuned by chemical design in principle, then it is
an additional adjustment knob for uniformly shifting the
multivalent binding free energy if tuning the particle con-
centration proves to be impractical. (An example would
be a particular target receptor surface that requires a
vanishingly small or infeasibly large bulk solution con-
centration of multivalent particles in order to reach a
desired binding equilibrium).
III. TARGETING A LOW-RECEPTOR-DENSITY
SURFACE WITH TWO COMPETING SPECIES
The binding free energy of a multivalent particle,
βG(NR), can be completely tailored by the parameters
f , NL, and z. This can be used to design a multiva-
lent species that binds strongly to a surface with a high
receptor density, while not binding to one with a lower
density. However, it is impossible to achieve the oppo-
site case with just one multivalent binder. As is apparent
in Figures 1a and b, the binding free energy cannot be
manipulated in such a way that the multivalent particle
only binds at low surface receptor concentration.
To solve this problem, we can introduce a second par-
ticle species that competes for surface binding with the
original species. The goal is to define the second species
such that it blocks the first from binding to the high-
receptor-density surface, but not the low-density surface.
We call this second species the “guards”, and the origi-
nal species the “attackers”. The forthcoming “Attacker
& Guard” strategy is graphically depicted in Figure 2,
showing the molecular ingredients, salient mathematical
parameters, and intended equilibrium distribution of at-
tackers and guards on the two receptor surfaces.
To start, the guards are defined to be a roughly
receptor-sized monovalent species. The free energy of
binding for a monovalent species is independent of the
surface receptor density. Each receptor has a partition
function of the form
qreceptor = 1 + zguarde
−βfguard , (7)
where fguard is the free energy for forming a guard-
receptor bond, and zguard is the guard fugacity. The first
term in qreceptor is the weight for when the receptor is
not bound to anything, and the second is for when it is
bound to a guard particle. The free energy of a single
receptor is then just − ln (qreceptor).
However, to compare the guard binding free energy
to the attackers, we must consider the total free energy
of guard binding over the full area a2 occupied by an
attacker. This quantity depends linearly on the number
NR of receptors within a
2:
βGguard(NR) = − ln
(
qNRreceptor
)
= −NR ln
(
1 + zguarde
−βfguard)
= −NRCguard. (8)
Here, the combined tunable guard parameter
Cguard ≡ ln
(
1 + zguarde
−βfguard) (9)
has been defined for notational clarity in subsequent
equations.
On the other hand, the free energy of the lattice site
when occupied by an attacker depends logarithmically on
NR in the lattice site, via Eq. 5:
βGattacker(NR) =−NL ln
(
1 +NRe
−βfattacker)− ln zattacker.
(10)
assuming no non-specific binding free energy contribution
βGNS . Importantly, we assume that when an attacker
is bound, it excludes all receptors over the area a2 from
binding to any guards. This assumption is most likely to
hold when the attacker is a solid structure like, e.g., a
ligand-coated nanoparticle, vesicle, or virus. The impli-
cations of this assumption breaking down are examined
later.
The different scaling of the attacker and guard binding
free energies (per lattice site) with NR can be exploited
as shown in Figure 3a. In this example, we suppose that
5FIG. 2. Graphical depiction of the “Attacker & Guard” targeting strategy, showing key ingredients, mathematical parameters,
and sought-after equilibrium binding distribution of particles. Upper half of image shows attackers, guards, and a receptor
surface, along with relevant mathematical parameters (described in main text). Lower half of image shows attackers and guards
in a hypothetical solution containing a low- and high-receptor-density surface. On the left, attackers and guards have just been
added, while on the right, equilibrium has been reached.
the low-density surface has NR = 4 ≡ N ′R, and the high-
density surface has NR = 10 ≡ N ′′R. The blue curve in
Figure 3a plots βGguard(NR) as a function of NR. The
slope of the line is controlled by the guard fugacity zguard
and binding strength fguard. The red curve in Figure
3a displays βGattacker(NR). The weaker logarithmic de-
pendence of βGattacker(NR) on NR has been exploited
to tune the attacker’s design (via NL, fattacker, zattacker)
such that: at N ′R, βGattacker(N
′
R) < βGguard(N
′
R); while
at N ′′R, βGguard(N
′′
R) < βGattacker(N
′′
R).
The resulting binding behaviour of the attackers and
guards is displayed in Figure 3b. The probability that a
surface site is occupied by an attacker is
P attackerb (NR) =
e−β∆G(NR)
1 + e−β∆G(NR)
, (11)
where
β∆G(NR) ≡ βGattacker(NR)− βGguard(NR). (12)
For comparison, we also plot the probability that a single
receptor is attached to a guard:
P guardb (NR) =
(
zguarde
−βfguard
1 + zguarde−βfguard
)
× (1− P attackerb (NR)) . (13)
These are derived in Appendix A.
In Figure 3, the guard and attacker fugacities have
been set to ln zguard = −2 and ln zattacker = −4.53. Using
Eq. 1, a rough feasibility check can be made for the molar
concentrations these fugacities correspond to assuming
that there is no non-specific binding free energy (βGNS)
contribution. For example, considering “receptor-sized”
guards of length 10nm (≈ 1 hemagglutinin unit on the
exterior of an influenza virus particle), and attackers of
size 100nm, then these fugacities correspond to guard
and attacker concentrations of around [Gu] ≈ 200 µM,
and [At] ≈ 18 nM. These concentrations, along with the
choices of βfguard = −4, NL = 4, and βfattacker = −3 in
that figure, are well within accessible experimental range.
At N ′R, the attackers are strongly bound, while at N
′′
R,
the guards outcompete the attackers for binding. The
value of NR where βGguard(NR) = βGattacker(NR) de-
fines the “switch point” between the two species. Com-
bining both species into the same system is essential, as
alone, one or the other species would strongly bind to
both the low- and high-density surfaces (dashed blue and
red lines in Figure 3a).
The effectiveness of the targeting recipe is assessed by
the difference in attacker binding probabilities at N ′R and
6(a)
(b)
FIG. 3. Binding free energy (a, via Eqs. 8 and 10) and
surface adsorption probability (b, via Eqs. 11 and 13) for
attackers (red curves) and guards (blue curves) as a func-
tion of the average number of receptors per surface lattice
site of area a2. Green vertical lines indicate the low-receptor-
density and high-receptor-density surfaces, with N ′R = 4 and
N ′′R = 10, respectively. In (b), solid lines are for when at-
tackers and guards coexist in the same system, while dashed
lines are for when they are separately in the system. Multi-
valent attacker parameters are NL = 4, βfattacker = −3, and
ln zattacker = −4.53, while monovalent guard parameters are
βfguard = −4 and ln zguard = −2. Attacker fugacity zattacker
has been chosen such that β∆G(N ′R) = −β∆G(N ′′R), indi-
cated as β∆G∗ in (a) here.
N ′′R, defined as
Effectiveness ≡ φ ≡ P attackerb (N ′R)−P attackerb (N ′′R). (14)
Values of φ near unity are optimal, 0 means that the
attackers bind equally well to N ′R and N
′′
R, while negative
values (approaching −1) mean that the attackers favour
binding to N ′′R rather than N
′
R.
In order to achieve an effectiveness φ of unity, the
attacker/guard binding free energy difference β∆G(NR)
must go to negative infinity at N ′R and positive infinity at
N ′′R. Therefore, to proceed further, we seek the attacker
and guard design parameters that lead to a given chosen
effectiveness φ.
By inspection of Figure 3a, the maximum possible ef-
fectiveness of an attacker+guard design is set by the slope
of the guard free energy (blue line) as a function of NR.
The larger and more negative the slope, the larger the
free energy difference between N ′R and N
′′
R. The connec-
tion between a desired φ, and the necessary Cguard, is
developed in the next section.
The remaining task is to find an optimal attacker de-
sign, i.e. NL, zattacker, and fattacker. The best attacker
design is one in which their free energy of binding (red
curve) as a function of NR is nearly constant between
N ′R and N
′′
R, so as to bisect the blue guard curve in this
interval in Figure 3a. Doing so obtains the most negative
β∆G(N ′R) and most positive β∆G(N
′′
R). Based on Eq.
10, this occurs when the attacker has few strong-binding
ligands.
The number of ligands NL and ligand/receptor bond-
ing strength fattacker of the attackers are set by chemi-
cal design. Supposing these are pre-defined for the time
being, we then seek the attacker fugacity (concentration)
zattacker that maximises the targeting effectiveness φ. At-
tackers can be readily titrated into a system so that the
level of control over zattacker is very high compared to the
molecular design. It is therefore a convenient experimen-
tal control parameter to optimise over for the attackers.
The attacker fugacity zattacker that maximises the tar-
geting effectiveness is where
dφ
d ln zattacker
= 0. (15)
This is carried out in Appendix B, where we find that
the largest effectiveness is obtained by choosing zattacker
such that
β∆G(N ′R) = −β∆G(N ′′R). (16)
We call this optimum “β∆G∗”: a free energy “gap” that
is directly tuned by the design of the guards and attack-
ers. Inserting the condition in Eq. 16 into Eq. 14 yields
Optimal Effectiveness ≡ φ∗ = e
−β∆G∗ − 1
e−β∆G∗ + 1
. (17)
Tuning of the attacker fugacity to satisfy this optimum
condition has been carried out in Figure 3a, and the sym-
metric free energy gap β∆G∗ is indicated. The “toler-
ance” of the targeting design is quantified by the width
of the optimum in targeting effectiveness at β∆G(N ′R) =
−β∆G(N ′′R) = β∆G∗:
Design Tolerance for φ∗ ≡ −
(
d2φ
[d ln zattacker]
2
)−1
≈ 1
2
e−β∆G
∗
. (18)
7Equations 17 and 18 indicate that the most effective
and most tolerant targeting design is obtained when the
free energy gap β∆G∗ is large and negative.
IV. OPTIMAL DESIGN OF ATTACKERS AND GUARDS
The quantity β∆G∗ is directly tuned by the molecular
design of the attackers and guards. The necessary β∆G∗
in order to achieve a given effectiveness φ∗ is obtained
by inverting Eq. 17, yielding β∆G∗needed = − ln
(
1+φ∗
1−φ∗
)
.
The free energy gap in terms of the attacker and guard
binding free energies is β∆G∗ = βGattacker(N ′R) −
βGguard(N
′
R), subject to the constraint βGattacker(N
′
R)−
βGguard(N
′
R) = βGguard(N
′′
R) − βGattacker(N ′′R) given by
Eq. 16.
These three relations, applied to the guard and at-
tacker binding free energies (Eqs. 8 and 10), result in
closed-form expressions for the necessary attacker and
guard solution concentrations [At]∗ and [Gu]∗ to achieve
a desired targeting effectiveness φ∗. The derivation is
carried out in Appendix C, resulting in
[At]∗ =
1
NAhbinda2
(qL(c′′R)
qL(c′R)
)NL
2
(
1 + φ∗
1− φ∗
)
c′′R+c
′
R
c′′
R
−c′
R
[qL(c′R)qL(c
′′
R)]
NL
2
; (19)
[Gu]∗ =
1
Kguardeq

(qL(c′′R)
qL(c′R)
)NL
2
(
1 + φ∗
1− φ∗
) 2NAa2(c′′R−c′R) − 1
 . (20)
where qL(c
′
R) and qL(c
′′
R) are dimensionless quantities
calculated by
qL(cR) =
(
1 +
cRK
attacker
eq
hbind
)
. (21)
The expressions are presented here in chemical equilib-
rium form, to facilitate experimental implementation.
Appendix C details the mathematical transformations in-
volved to translate the statistical mechanical theory into
the form shown here.
The molar equilibrium association constants Kattackereq
and Kguardeq are for, respectively: binding between a free
receptor and a single free ligand on the attacker; and be-
tween a free receptor and a guard particle in solution.
The quantities c′R and c
′′
R are “surface receptor molari-
ties” (in units of moles of receptors per unit surface area)
on the low- and high-density surfaces, respectively, and
a is the diameter of the attacker (including its ligand
corona). These are related to the previously-employed
surface densities σR by cR = σR/NA. The quantity hbind
is the equilibrium binding height of the attacker; its pre-
cise definition depends on the type of construct the at-
tacker is, to be discussed shortly. Finally, NL is the effec-
tive number of ligands on the attacker species that can
access the surface for receptor binding at any given time.
Equations 19 and 20 provide physical insight. As the
desired effectiveness φ∗ is increased to unity, then the re-
quired attacker and guard concentrations (or association
constants) grow very large. Therefore, the low-receptor
density surface can be targeted more effectively when the
attackers and guards have a larger overall binding affin-
ity. This is the opposite to standard one-component mul-
tivalent targeting of high-density surfaces, in which weak
ligand-receptor bonds yield higher selectivity.
The remainder of this section takes a closer look at
the guard and attacker parameters in Eqs. 19 and 20.
The kinetics involved to reach binding equilibrium be-
tween the two competing adsorbers are illustrated, and a
suggested “recipe” for adding attackers and guards that
circumnavigates potential kinetic barriers is outlined. To
finish, factors that enhance the tolerance of the design are
discussed, while also remarking on effects not considered
in our theory which might reduce the targeting effective-
ness.
A. Equilibrium constants & attacker binding height in the
context of experiment
The binding constant Kattackereq for the attacker ligands
includes the enthalpic contribution to the ligand/receptor
bond, as well as the extra (entropic) free energy cost
∆Glig,cnf for bond formation. Usually in experiment, the
ligand/receptor binding constant is only measured for the
case where the receptor and ligand structures are free
in solution and untethered to any host surfaces. This
reference ligand/receptor binding constant, “K◦,attackereq ”,
is mapped to the binding constant for the ligands when
8FIG. 4. Possible definitions for the equilibrium binding
height parameter hbind, depending on the multivalent at-
tacker structure. Top image depicts a multivalent particle
with a solid core and flexible ligands, interacting with a sur-
face of short/inflexible receptors. Middle image is a star
polymer-like structure or dendrimer-like structure interact-
ing with short/inflexible receptors. Finally, bottom image is
a spherical structure with densely-packed short/inflexbile lig-
ands (e.g. like an influenza virus) interacting with flexible
receptors.
attached to the attacker particle by
Kattackereq = K
◦,attacker
eq e
−β∆Glig,cnf . (22)
Detailed discussions and models for approximating the
extra entropic free energy penalty ∆Glig,cnf for lig-
and/receptor binding are given in Refs. 6 and 8.
The quantity hbind is a binding distance parameter.
It controls the receptor “effective molarity” that the lig-
ands on an attacker “see” when the attacker is surface-
bound.19 Appendix C describes this in greater mathe-
matical detail.
The choice of how to precisely define hbind depends on
the type of construct that the attacker is, as illustrated
in Figure 4. For example, if the attacker is a star poly-
mer or dendrimer construct31, then hbind should be taken
to be the distance between the receptor surface and the
center of the star. If the attacker is a solid particle-type
construct like a DNA-coated nanoparticle or a surface-
functionalised vesicle, then hbind should be defined as
the equilibrium distance between the outer surface of the
attacker, and the receptor surface.
In the latter case, whether or not hbind should include
the lengths of the receptors or ligands depends on how
densely packed they are on their respective surfaces. For
example, if the attacker has a dense packing of binding
ligands (like, e.g., the influenza virus), then one could
argue that hbind should be measured from the exterior of
the ligand corona to the receptor substrate. However, if
the ligands are long and flexible, or at a relatively low
surface density, then hbind is better defined as going all
the way to the solid exterior of the attacker.
For purpose of demonstration, Figure 5 shows
experimentally-relevant examples of how the optimal at-
tacker and guard concentrations given by Eqs. 19 and
20 vary with choice of binding constants. The diameter
of an attacker is set to a = 50nm, with an equilibrium
binding height hbind = 15nm. The low-receptor-density
surface is chosen to have σ′Ra
2 = 5 receptors per attacker
“footprint”, and the high-density surface σ′′Ra
2 = 10. The
attacker particles are defined to have NL = 4. Results
have been calculated for three choices of desired targeting
effectiveness φ∗.
In Eq. 20, we immediately see that the optimal guard
concentration always scales with the binding constant
Kguardeq as
[Gu]∗ ∝ 1
Kguardeq
The attackers behave in a more complex way. However,
when the attacker ligands are strong-binding, then the
ratio (qL(c
′′
R)/qL(c
′
R)) → (c′′R/c′R) in Eqs. 19 and 20. In
this limit, the optimal attacker concentration scales as
[At]∗ ∝
(
1
Kattackereq
)NL
This scaling relation is noted in the upper panel of Figure
5 when the attacker ligands are strong-binding. The loga-
rithm of [At]∗ varies nearly linearly with the logarithm of
the reciprocal ligand/receptor binding constant (i.e. the
dissociation constant Kattackerd ) when K
attacker
d is small.
For relatively strong-binding ligands, where Kattackerd is
around 1 micromolar, then the optimal solution concen-
tration of attackers is in the micromolar to nanomolar
range. Weakening the ligand/receptor Kattackerd brings
[At]∗ to higher concentrations. Choosing a larger target-
ing effectiveness φ∗ also acts to increase the optimal [At]∗
range.
The story for the guards is similar in the lower panel of
Figure 5. The scaling of [Gu]∗ ∝ 1
Kguardeq
is clear, though
9FIG. 5. Logarithm of the optimal attacker (upper panel) and guard (lower panel) concentrations as a function of reciprocal
binding constants 1/Kattackereq and 1/K
guard
eq (in units of micromolar). Results are calculated using Eqs. 19 and 20. Attackers
are defined to have NL = 4, a diameter of a = 50nm, and an equilibrium binding height hbind = 15nm. The low- and high-
receptor-density surfaces have σ′Ra
2 = 5 and σ′′Ra
2 = 10 receptors per attacker footprint a2, respectively. Calculations are
displayed for three choices of targeting effectiveness φ∗ = 0.95, 0.8, and 0.5 (red, green, blue). For guard calculations, attacker
ligand/receptor binding constant is set to 1/Kattackereq = 10 micromolar.
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it is less steep than for the attackers, due to the lack
of the exponent NL on the (monovalent) guards. When
the guard dissociation constant is around one micromo-
lar, the optimal concentration is also in the micromolar
range. Increasing the dissociation constant into the mil-
limolar range accordingly brings the optimal guard con-
centration into that range as well.
B. Kinetics on the road to equilibrium & suggested
sequence of ingredients
Strong-binding attackers and guards have the limita-
tion of long equilibration times, since both species will
have strong affinity for both receptor surfaces. The de-
sired equilibrium binding distribution of attackers and
guards shown in Figure 3b may therefore take a very long
time to achieve, as the unbinding rates of the attackers
and guards on either surface decreases exponentially as
the overall binding free energy grows larger and more
negative/favourable.
For example, monovalent binders with a binding free
energy of f (corresponding to an equilibrium association
constant of Keq) have an unbinding timescale that goes
as the Arrhenius form
τmonooff
τ0
= e−βf ∝ Keq, (23)
where τ0 is a characteristic timescale. (This form as-
sumes that there is no appreciable activation barrier to
unbinding.) The unbinding timescale τmonooff grows longer
for strong-binding (e.g. larger negative βf , larger Keq)
particles. For multivalent binders with ligand/receptor
bonds of strength fLR, the unbinding timescale increases
exponentially with the average number m¯ of bonds:31
τmultioff (m¯)
τ0LR
=
e−βGNS
m¯
e−βm¯fLR ∝ (KLReq )m¯ , (24)
where τ0LR is the timescale (reciprocal rate) of lig-
and/receptor association when both entities are free in
solution at 1 molar reference concentration, and βGNS
contains all of the non-specific interaction free energy
contributions between the multivalent particle and the
target surface as noted earlier in Eq. 2.
When the ligands on the attackers are strong-binding,
as the present strategy calls for, then τmultioff (m¯) can
potentially grow very long compared to τmonooff for the
guards. To pre-emptively circumvent this kinetic bar-
rier, we can envision the recipe depicted in Figure 6 for
reaching an attacker & guard binding equilibrium:
1. Add monovalent guards.
2. Equilibrate.
3. Add multivalent attackers.
4. Equilibrate again.
By this route, the only exchange necessary is on the low-
receptor-density surface, where monovalent guards must
unbind in order to allow the more favourably-binding
multivalent attackers to attach (Figure 6, lower right).
In experimental design, the guard Kguardeq can be chosen
to be a strong-binding yet kinetically-reasonable value,
and then the concentration [Gu]∗ can be chosen via Eq.
20. The guard binding constant will therefore set the
timescale τoff that must be waited for the final equilib-
rium to be reached.
C. Making a more tolerant design
In Eq. 18, we found that the tolerance of the Attacker
& Guard strategy grows exponentially larger by designing
a larger (more negative) free energy gap β∆G∗. Let us
now examine in detail how β∆G∗ depends on the attacker
and guard parameters, assuming that we always choose
the optimal concentrations given by Eqs. 19 and 20.
Equations 8 and 10 can be used to write two
equivalent equations for β∆G∗ by invoking the op-
timisation condition found in Eq. 16. These
are: (β∆G∗)1 = βGattacker(N ′R) − βGguard(N ′R); and
(β∆G∗)2 = βGguard(N ′′R) − βGattacker(N ′′R). Given that
[(β∆G∗)1 + (β∆G∗)2]/2 = β∆G∗ by definition, then we
arrive at
β∆G∗ =
NL
2
ln
(
qL(c
′′
R)
qL(c′R)
)
− C∗guard
(
NAa
2(c′′R − c′R)
2
)
.
(25)
The factor of Avogadro’s number NA is necessary in the
second term, in order to properly convert the surface
receptor molarities c′R and c
′′
R into particle counts. In
terms of experimental units, the guard design parameter
Cguard = ln
(
1 + [Gu]Kguardeq
)
; this is numerically identi-
cal to the statistical-mechanical definition in Eq. 9. For
further discussion on this equivalence, refer back to Eq.
C14 in Appendix C.
Equation 25 has two distinct terms. The first is a pos-
itive (unfavourable) contribution that depends on the at-
tacker design parameters Kattackereq (in the qL(cR) factors)
and NL (in the prefactor). The second term is a nega-
tive (favourable) contribution that depends on the guard
design Cguard.
These two terms can be analysed in the context of
Figure 3a. Clearly, the only way to increase the size of
the free energy gap β∆G∗ is to make the slope of the
blue (guard) free energy curve more negative. This cor-
responds to choosing a larger Cguard (either by choosing
a larger guard concentration, or larger binding constant
Kguardeq ). Doing so increases the potential effectiveness φ
of the recipe in Eq. 17, and also the tolerance to attacker
concentration variations around the optimum value.
The attackers, on the other hand, have a less obvi-
ous influence on the size of the gap. For extremely
weak-binding ligands, then the ratio qL(c
′′
R)/qL(c
′
R) in
Eq. 25 approaches unity, causing that term to vanish
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FIG. 6. Graphical depiction of a kinetically-facile approach to reaching Attacker & Guard equilibrium in a hypothetical
solution containing a low- and high-receptor-density surface. Adding guards (top left) to the solution and then equilibrating
leads guards to bind to receptors on both surfaces (upper right). Attackers are then titrated into the solution (lower right),
and they outcompete for binding on the low-density surface due to their more favourable binding free energy at that receptor
density (lower left).
to zero so that β∆G∗ is more negative. However, this
limit is not experimentally realistic. On the other hand,
making the ligands stronger-binding saturates the ratio
(qL(c
′′
R)/qL(c
′
R)) → (c′′R/c′R) as noted previously. It is
then the number of ligandsNL on the attacker that serves
to multiply the logarithm of this ratio in Eq. 25, suggest-
ing that attackers with more ligands lead to a potentially
less effective and less tolerant design. We return to this
point shortly in more quantitative terms.
A beneficial side-effect of Eq. 25 is that the targeting
effectiveness φ is not particularly sensitive to attacker
concentration variations around the optimal value given
by Eq. 19. This can be seen in the numerical examples in
Figure 5 (upper panel). The attacker concentration only
shifts the binding free energy of the attackers by a con-
stant logarithmic factor ln [At] (appearing as ln zattacker
in Eq. 10). For example, shifting the attacker bind-
ing free energy (red) curve in Figure 3a downward by,
say, 2kT , corresponds to increasing the attacker particle
concentration by a large factor of e2 ≈ 7.4. However,
this will have little impact on the effectiveness φ, since
increasing β∆G(N ′R) by −2kT and β∆G(N ′R) by 2kT
leads both to still be very near β∆G∗ (assuming that
β∆G∗ is already somewhat large and negative). Results
in the upper panel of Figure 5 illustrate this point nicely.
Varying the attacker molar concentration by a factor of
102 (i.e. from the red to the green dataset in that fig-
ure) only corresponds to a change in effectiveness from
φ∗ = 0.95 to 0.8.
In contrast, the targeting effectiveness is more sensitive
to variations in guard concentration [Gu], as this factor
goes into the slope of the guard binding free energy in
Figure 3a (blue curve) as zguard in Eq. 8. For example,
in the lower panel of Figure 5, changing the guard con-
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centration only by a factor of two (i.e. going from the
red curve to the green curve) corresponds to the same
change in effectiveness from φ∗ = 0.95 to 0.8 enacted by
changing the attacker concentration by a factor of 100.
The number of receptors N ′R and N
′′
R per lattice site on
the two surfaces also plays a role in β∆G∗. In particular,
as the disparity between N ′R and N
′′
R grows larger, an
attacker design with weaker binding or lower concentra-
tion can be employed in order to obtain a given targeting
effectiveness φ∗. Numerical examples of this are given in
Figure 7, showing how [At]∗ varies as the receptor con-
centration σ′R on the low-density surface grows closer to
that on the high-density surface (having σ′′Ra
2 = 10).
A qualitatively similar trend is observed for the selec-
tions of ligand/receptor binding constant Kattackereq and
targeting effectiveness φ∗ = 0.95 and 0.5. As σ′R grows
closer to σ′′R, the attacker and guard recipe demands a
larger attacker binding constant or bulk concentration.
When lower targeting effectiveness is sought, then lower
values for these two parameters are called for. Figure 7
also shows how the optimal guard concentration [Gu]∗
varies comparatively little with σ′R at fixed σ
′′
R, assuming
a moderate-binding 1/Kguardeq = 10 micromolar.
A somewhat counter-intuitive observation in Eq. 25 is
that increasing the number of ligandsNL on the attackers
actually leads to a smaller free energy gap. Looking at
Figure 3a, a larger β∆G∗ is obtained when the attacker
free energy (red curve) approaches behaving like a hori-
zontal line between N ′R and N
′′
R. However, increasing NL
causes the attacker free energy to exhibit a more negative
gradient for larger values of NR, as demonstrated in Fig-
ure 1b. Larger attacker valence therefore limits the tar-
geting effectiveness of the attacker/guard recipe, again
in contrast to standard multivalent reasoning. On the
other hand, choosing small NL has kinetic consequences,
as attackers with fewer ligands will exhibit a slower rate
of surface adsorption.
Figure 8 presents numerical results for how the opti-
mal concentrations [At]∗ and [Gu]∗ vary with NL. Ex-
amining Eq. 19 and taking the strong-ligand limit where
(qL(c
′′
R)/qL(c
′
R))→ (c′′R/c′R) yields a scaling of
ln [At]∗ ∝−NL ln
(
Kattackereq
√
c′Rc
′′
R
hbind
)
+
NL
2
(
c′′R + c
′
R
c′′R − c′R
)
ln
(
c′′R
c′R
)
. (26)
The first term in this expression tends to dominate in
Figure 8 (upper panel), giving rise to the linear trends.
As intuition would suggest, adding more ligands with the
same binding strength Kattackereq to the attackers leads to
a lower optimal solution concentration [At]∗. Increas-
ing the intended targeting effectiveness φ∗ just causes a
uniform upward shift in the optimal concentration [At]∗.
However, the optimal guard concentration [Gu]∗ changes
little with NL in Figure 8 (lower panel). In the strong-
ligand limit for the attackers, the optimal guard concen-
tration in Eq. 20 scales as
ln [Gu]∗ ∝ NL
a2 (c′′R − c′R)
ln
(
c′′R
c′R
)
. (27)
This lacks the strong binding constant dependence like
the attackers.
D. Complications to effective targeting, and to the
present theory
It has been assumed that the attackers are large
enough when bound so as to sterically exclude all recep-
tors in their surface “footprint” of area a2 from binding to
any guard particles. This might be difficult to achieve in
experiment; guard particles might slip beneath the bound
attackers to occupy some of the receptors, thereby reduc-
ing the statistical average number of attackers bound on
the target low-density surface. The quantitative result
in Figure 3b would be a lowering of the red curve and a
raising of the blue curve in the low-receptor range (i.e.
on the surface(s) where attackers dominate). The overall
targeting effectiveness φ (by Eq. 14) will be accordingly
reduced. In general, the more easily that guards can pen-
etrate beneath bound attackers, the lower the resulting
effectiveness of the strategy will be. One possibility is
to add bulky groups to the guards, so that they are less
likely to invade attacker-occupied surface territory.
In addition to ligand-receptor interactions, it was
noted in Eq. 2 that multivalent particles can also have a
non-specific interaction free energy βGNS with their tar-
get surface. However, as demonstrated in Eq. 5, any such
contribution just becomes an additive factor in the multi-
valent binding free energy. Therefore, the only influence
of βGNS is to shift the attacker binding free energy (e.g.
red curve, Figure 3a) by a constant factor. This will
quantitatively shift the predicted [At]∗ upward if βGNS
is positive, or downward if βGNS is negative. However,
it will not affect the possibility of selectively targeting
the low-density surface.
Early in our discussion, we made the approximation
that the attacker binding free energy follows the form
of Eq. 5, so that we could proceed analytically. This
expression over-estimates the binding free energy for a
multivalent particle / surface interaction in which the
number of receptors within binding range of the particle
is near or less than the number of ligands on the particle,
particularly if the ligands are strong-binding. However,
the molecular recipe arising out of our discussion is more
selective when the multivalent attackers have few ligands
(as opposed to many). In cases where the number of re-
ceptors within binding range of the attacker is small rel-
ative to the number of ligands on the particle, then the
true binding free energy will be less favourable (less neg-
ative) than predicted by Eq. 5. The predicted optimal
attacker concentration [At]∗ will therefore be underesti-
mated by Eq. 19 for the system at hand. This quan-
titative difference does not prevent selective targeting of
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FIG. 7. Logarithm of the optimal attacker concentration [At]∗ as a function of the number of receptors per attacker footprint,
σ′Ra
2, on the low-density surface. The high-density surface is fixed at σ′′Ra
2 = 10. Attackers have NL = 4 ligands, diameter
a = 50nm, and an equilibrium binding height hbind = 15nm. Results for three choices of ligand/receptor dissociation constants
1/Kattackereq in the micromolar range are given (blue, green, and red). Black curves are the logarithm of the optimal guard
concentration [Gu]∗ vs. σ′Ra
2 when their dissociation constant is 1/Kguardeq = 10 micromolar and when attackers also have
1/Kattackereq = 10 micromolar. For all datasets, solid lines are for targeting effectiveness φ
∗ = 0.95, and dashed lines are for 0.5.
the low-receptor-density surface, nor does it qualitatively
alter the targeting recipe presented here.
V. CONCLUSIONS & EXPERIMENTAL
IMPLEMENTATION
Multivalent particles cannot, on their own, selectively
bind to a surface with a low density of receptors, while
not binding to one with a higher density of the same re-
ceptors in the same system. To address this challenge,
we have defined a strategy using competitive binding of
two particle species. The first species, called “guards”,
are monovalent particles that bind equally well to any re-
ceptor on any surface. A second species, called “attack-
ers”, are multivalent particles designed to outcompete
the guards for binding on the low-receptor-density sur-
face, but not on the surface with higher receptor density.
At equilibrium, therefore, the attackers occupy the low-
density surface, while the guards occupy the high-density
surface.
An optimal targeting recipe, and several guidelines,
have been derived and deduced in our discussion that
can be directly employed in experiment. These are now
summarised:
• The guards are small (receptor-sized) monovalent
particles, with a receptor association constant of
Kguardeq , and a solution concentration of [Gu]. These
particles are added first in the system, and allowed
to bind and equilibrate on both receptor surfaces.
• The attackers are larger multivalent particles at a
solution concentration of [At], each having NL lig-
ands that can reach multiple receptors when the
host multivalent particle is at a given fixed surface
position. Their ligand-receptor association con-
stant is Kattackereq . These particles are added sec-
ond into the system. The attackers will, by de-
sign, outcompete the guards for binding on the low-
receptor-density surface, but not the high-receptor-
density surface.
• Equations 19 and 20 define the optimal attacker
and guard solution concentrations, given their cho-
sen individual ligand-receptor binding constants
Kattackereq and K
guard
eq , the attacker valence NL,
and the surface receptor molarities c′R and c
′′
R on
the low- and high-receptor-density surfaces, respec-
tively. These equations are employed by inputting
a desired “targeting effectiveness” parameter φ∗ be-
tween 1 (perfect attacker binding selectivity for the
low-receptor-density surface) and 0 (no binding se-
lectivity).
• More effective targeting (φ∗ approaching 1) re-
quires stronger-binding attackers and guards, at
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FIG. 8. Logarithm of the optimal attacker (top panel) and guard (bottom panel) concentrations as a function of the number
of ligands NL on the attackers. Attackers have diameter a = 50nm and an equilibrium binding height hbind = 15nm. The
low- and high-receptor-density surfaces have σ′Ra
2 = 5 and σ′′Ra
2 = 10 receptors per attacker footprint a2, respectively. Results
are presented for three choices of micromolar-range dissociation constants 1/Kattackereq and 1/K
guard
eq (red, green, blue), and for
two choices of targeting effectiveness φ∗: 0.95 (solid) and 0.5 (dashed). For guard calculations in lower panel, 1/Kattackereq = 10
micromolar.
larger solution concentrations. This is contrary to
standard multivalent targeting. However, stronger-
binding guards also lead to longer equilibration
time on the low-density surface when the at-
tackers are added. The larger the difference
between the receptor densities on the two sur-
faces, the weaker the attacker and guard binding
strengths/concentrations can be in order to achieve
a given targeting effectiveness.
• More effective targeting occurs when the number of
ligands on the attackers is small. However, multiva-
lent particles with fewer ligands will have a longer
timescale for forming bonds with surface receptors.
The best approach is therefore to use strong-binding
guards that still have a reasonable unbinding timescale,
and comparably strong-binding attackers that have sev-
eral ligands. The best design can be identified by explor-
ing a range of targeting effectiveness values φ∗ in Eqs. 19
and 20, to find arrive at a guard/attacker motif that is ki-
netically and thermodynamically suitable. After putting
the guards into the system at a concentration of [Gu]∗
based on Eq. 20, attackers can be titrated in until they
are near a concentration of [At]∗ given by Eq. 19. Val-
ues of [At] > [At]∗ may work equally well, in order to
overcome additional non-specific binding free energy con-
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tributions between the attackers and the target surface;
the effectiveness of targeting does not depend strongly
on [At] above [At]∗.
A prime application for this targeting strategy is to
selectively image cell surfaces, or regions of cell surfaces,
with locally low receptor density compared to other cell
surfaces in the same system in vitro. This could be
done by attaching a fluorescent probe to the attack-
ers, but not the guards. Examples of promising struc-
tures that could act as attackers include ligand-coated
nanoparticles, functionalised vesicles, DNA origami /
dendrimer constructs, star polymers, or modified viruses.
The binding equilibrium constants of the guards and at-
tackers could be tuned by a DNA approach, e.g. like
in DNA-PAINT.73 The attacker and guard recipe could
also be used to selectively sequester or aggregate a popu-
lation of nanoscopic entities in solution with a low re-
ceptor density, with attackers acting as the aggrega-
tion/sequestration agent.
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Appendix A: Multivalent attacker and monovalent guard
binding probabilities
The partition function for a surface lattice site is given,
based on Eqs. 8 and 10, as
Q(NR) =
(
1 + zguarde
−βfguard)NR
+ zattacker
(
1 +NRe
−βfattacker)NL
= Qguard(NR) +Qattacker(NR). (A1)
The first term in Q(NR) represents all possible guard
binding states, and the second term is for all attacker
binding states. The state in which the lattice site has nei-
ther an attacker nor any guards bound, having a weight
of unity, is included in the first term of Q(NR). This
partition function also includes the state in which an at-
tacker is within the surface lattice site, but has no ligands
bound to receptors.
The probability that a surface lattice site is occupied
by an attacker is just the ratio of Qattacker(NR) to Q(NR)
for a given number of receptors NR in the lattice site:
P attackerb (NR) =
Qattacker(NR)
Qattacker(NR) +Qguard(NR)
=
e−βGattacker(NR)
e−βGattacker(NR) + e−βGguard(NR)
. (A2)
By defining the quantity
β∆G(NR) = βGattacker(NR)− βGguard(NR), (A3)
then P attackerb (NR) reduces to the simple form
P attackerb (NR) =
e−β∆G(NR)
1 + e−β∆G(NR)
(A4)
as shown in Eq. 11.
The probability that a single receptor on the surface is
occupied by a monovalent guard is found by
P guardb (NR) =
1
NR
d lnQ(NR)
dβµguard
, (A5)
where βµguard = ln zguard is the chemical potential of the
guards in solution. This leads to
P guardb (NR) =
(
zguarde
−βfguard
1 + zguarde−βfguard
)(
1− P attackerb (NR)
)
,
(A6)
shown as Eq. 13 in the main text.
Appendix B: Optimal targeting effectiveness and tolerance
The targeting effectiveness is defined as
φ ≡ P attackerb (N ′R)− P attackerb (N ′′R), (B1)
where
P attackerb (NR) =
e−β∆G(NR)
1 + e−β∆G(NR)
. (B2)
The free energy difference β∆G(NR) is
β∆G(NR) = βGattacker(NR)− βGguard(NR)
= −NL ln [qL(NR)]− ln zattacker +NRCguard, (B3)
where
qL(NR) =
(
1 +NRe
−βfattacker) (B4)
is the partition function for one ligand on the attacker
given NR possible receptors to attach to nearby.
Choosing the parameter Cguard effectively sets the
guard binding free energy and fugacity in solution. In
experiment, it is also reasonable to assert that the num-
ber of ligands NL and ligand/receptor binding free en-
ergy fattacker have been set based on the chemical design
of the attackers. Thus, the remaining free variable to
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optimize is the attacker fugacity zattacker—that is, the
solution concentration [At] of attackers that maximises
the targeting effectiveness φ.
The attacker fugacity yielding the largest possible ef-
fectiveness φ is obtained where
dφ
d ln zattacker
=
d(β∆G(N ′′R))
d ln zattacker
e−β∆G(N
′′
R)(
1 + e−β∆G(N ′′R)
)2
− d(β∆G(N
′
R))
d ln zattacker
e−β∆G(N
′
R)(
1 + e−β∆G(N ′R)
)2 = 0. (B5)
Inspecting Eq. B3, the two derivatives of β∆G(NR) with
respect to ln zattacker are identical and independent of
NR. Thus, Eq. B5 is zero when either β∆G(N
′
R) =
β∆G(N ′′R), or β∆G(N
′
R) = −β∆G(N ′′R). The first solu-
tion yields an effectiveness of zero via Eq. B1, which is
obviously not the solution we want. The second solution,
β∆G(N ′R) = −β∆G(N ′′R) ≡ β∆G∗, (B6)
inserted into Eq. B1 yields the optimal effectiveness
φ∗ ≡ e
−β∆G∗ − 1
e−β∆G∗ + 1
. (B7)
This is given as Eq. 17 in the main text.
To ensure that β∆G(N ′R) = −β∆G(N ′′R) corresponds
to a maximum in Eq. B1, we check the sign of the second
derivative of the function φ with respect to ln zattacker at
β∆G(N ′R) = −β∆G(N ′′R) = β∆G∗:
d2φ
[d ln zattacker]
2 = 2e
−β∆G∗
[
1− e−β∆G∗
(1 + e−β∆G∗)3
]
. (B8)
The second derivative is always negative, and therefore
the condition β∆G(N ′R) = −β∆G(N ′′R) always corre-
sponds to a maximum, as long as β∆G∗ < 0. This is
true for any design which selectively targets the attackers
to the low-receptor-density surface. When β∆G∗ << 0,
then
−
(
d2φ
[d ln zattacker]
2
)−1
≈ 1
2
e−β∆G
∗
≡ Design Tolerance. (B9)
This illustrates how designing the attackers and guards
to have a more negative β∆G∗ causes the design to be
more robust/tolerant to variations in molecular construc-
tion and concentration.
Appendix C: Optimal attacker and guard design parameters
The binding free energies for guards (βGguard(NR))
and attackers (βGattacker(NR)) are given by Eqs. 8 and
10, respectively. Guards are defined by the choice of
the parameter Cguard, and attackers are given a pre-
defined valence NL and ligand/receptor binding free en-
ergy fattacker. In Appendix B, we showed that the
choice of attacker fugacity zattacker that maximises the
effectiveness φ corresponds to when βGattacker(N
′
R) −
βGguard(N
′
R) = βGguard(N
′′
R) − βGattacker(N ′′R). With
Eqs. 8 and 10, this condition yields the equation
ln zattacker =
(N ′R +N
′′
R)
2
Cguard − NL
2
ln [qL(N
′
R)qL(N
′′
R)]
(C1)
where qL(NR) is given by Eq. B4.
Next, the relation β∆G∗ = − ln
(
1+φ∗
1−φ∗
)
=
βGattacker(N
′
R) − βGguard(N ′R) from Eq. 17 allows us
to write another equation with Eqs. 8 and 10:
−ln
(
1 + φ∗
1− φ∗
)
= −NL ln [qL(N ′R)]−ln zattacker+N ′RCguard
(C2)
Isolating ln zattacker in this equation and then putting it
back into Eq. C1 allows us to solve for the optimal Cguard
given a choice of targeting effectiveness φ∗:
C∗guard =
(
2
N ′′R −N ′R
)
ln
(qL(N ′′R)
qL(N ′R)
)NL
2
(
1 + φ∗
1− φ∗
)
(C3)
Putting this back into Eq. C1 then yields
ln z∗attacker =
(
N ′′R +N
′
R
N ′′R −N ′R
)
ln
(qL(N ′′R)
qL(N ′R)
)NL
2
(
1 + φ∗
1− φ∗
)
− NL
2
ln (qL(N
′
R)qL(N
′′
R)). (C4)
Equations C3 and C4 can be readily converted into a
chemical equilibrium notation. First, all instances of N ′R
and N ′′R can be identically expressed in terms of average
surface receptor densities σ′R and σ
′′
R. (Recall that the
receptor density σR is related to NR by NR = a
2σR; the
length a is the diameter of one attacker particle, and a2
therefore measures the area over which the particle can
bind to receptors on the surface.) This substitution leads
to
C∗guard =
[
2
a2 (σ′′R − σ′R)
]
ln
(qL(σ′′R)
qL(σ′R)
)NL
2
(
1 + φ∗
1− φ∗
)
(C5)
ln z∗attacker =
(
σ′′R + σ
′
R
σ′′R − σ′R
)
ln
(qL(σ′′R)
qL(σ′R)
)NL
2
(
1 + φ∗
1− φ∗
)
− NL
2
ln (qL(σ
′
R)qL(σ
′′
R)). (C6)
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where
qL(σR) =
(
1 + a2σRe
−βfattacker) (C7)
The remaining challenge is to express the following quan-
tities in terms of the receptor binding constant Kattackereq
for ligands on the attacker, the guard binding constant
Kguardeq , and guard/attacker molar concentrations [Gu]
and [At]:
C∗guard = ln
(
1 + zguarde
−βfguard)∗ (C8)
ln z∗attacker (C9)
qL(σR) =
(
1 + a2σRe
−βfattacker) (C10)
This process is now described in detail.
Recall that the equilibrium constant Keq for two bind-
ing entities “B” and “R”, in a hypothetical solution, is
defined as
Keq =
[BR]
[B][R]
. (C11)
Here, [BR] is the equilibrium concentration of B bound
to R, while [B] and [R] are the equilibrium concentrations
of unbound B and R. Let’s suppose that species R are
receptors on a surface, while species B are binders in so-
lution above the surface. If we go to the grand-canonical
limit where the number of B particles is far in excess of
the number of R particles, then [B] ≈ [B]◦, where [B]◦ is
the (fixed) solution concentration of B regardless of how
many are bound to R. This leads to
Keq =
1
[B]◦
(
[BR]
[R]
)
=
1
[B]◦
(
NR,bound
NR,free
)
(C12)
where NR,bound and NR,free are the number of receptors
that are bound to B, and unbound, respectively. The
number of unbound receptors at equilibrium is given by
NR,free = NR−NR,bound, where NR is the total number
of receptors on the surface. This is directly related to
the equilibrium binding free energy βf of B to R by the
statistical mechanical relationship(
NR,bound
NR −NR,bound
)
= z([B]◦)e−βf , (C13)
where z([B]◦) is the fugacity corresponding to the solu-
tion concentration [B]◦. Bringing the concentration fac-
tor [B]◦ onto the left-hand side of Eq. C12 yields
Keq[B]
◦ = z([B]◦)e−βf . (C14)
This is the direct relationship between the experimen-
tal quantity Keq[B]
◦ and the statistical thermodynamic
quantity z([B]◦)e−βf .
Using Eq. C14, we can immediately convert
zguarde
−βfguard in Eq. C8 into experimental units for the
guards:
zguarde
−βfguard = [Gu]Kguardeq , (C15)
where [Gu] is the molar solution concentration of the
guards.
Next, the fugacity zattacker of the attackers is related
to their molar solution concentration [At] via Eq. 1:
zattacker = [At]NAhbinda
2, (C16)
where hbinda
2 is the “localisation volume” for placing
the ligands of the particle in contact with the surface
receptors.
Turning lastly to qL(σR), the quantity σRa
2 acts as a
two-dimensional receptor fugacity and exp (−βfattacker)
is the binding strength term. Thus, we can again invoke
Eq. C14 to write Eq. C10 as
qL([R]eff) =
(
1 + [R]effe
−βfattacker) (C17)
where [R]eff is the effective molarity of receptors on the
surface, as seen by ligands on bound attackers. The effec-
tive molarities on the low- and high-density surfaces are
related to the surface (number) densities σ′R and σ
′′
R via
the equilibrium binding distance hbind of the attacker:
[R]′eff =
σ′R
NAhbind
=
c′R
hbind
(C18)
[R]′′eff =
σ′′R
NAhbind
=
c′′R
hbind
(C19)
For notational clarity, the molar surface receptor den-
sity cR = σR/NA has been defined, having dimensions of
moles of receptors per unit surface area. Re-expressing
Eq. C17 in terms of cR and hbind yields
qL(cR) =
(
1 +
cRK
attacker
eq
hbind
)
(C20)
These transformations enable us to write the expres-
sions for the optimal guard design C∗guard (Eq. C5) and
attacker fugacity z∗attacker (Eq. C6) in terms of experi-
mental quantities:
ln [At]∗ =
(
c′′R + c
′
R
c′′R − c′R
)
ln
(qL(c′′R)
qL(c′R)
)NL
2
(
1 + φ∗
1− φ∗
)
− NL
2
ln (qL(c
′
R)qL(c
′′
R))− ln
(
NAhbinda
2
)
(C21)
ln
(
1 + [Gu]∗Kguardeq
)
=
[
2
NAa2 (c′′R − c′R)
]
× ln
(qL(c′′R)
qL(c′R)
)NL
2
(
1 + φ∗
1− φ∗
).
(C22)
where qL(cR) is calculated by Eq. C20.
In this form, we have assumed that the ligand/receptor
binding constants Kguardeq and K
attacker
eq , as well as the
18
number of ligands NL on the attackers, are set based on
the chemical construction of the attackers and guards.
Achieving the optimum targeting effectiveness is thus left
to tuning of the attacker and guard solution concentra-
tions to the optimal values [At]∗ and [Gu]∗. The explicit
equations for these two quantities are obtained by isolat-
ing [At]∗ and [Gu]∗ in Eqs. C21 and C22. This is done
to yield Eqs. 19 and 20 in the main text.
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